Details zur Publikation |
| Kategorie | Textpublikation |
| Referenztyp | Zeitschriften |
| DOI | 10.1007/s00204-023-03655-5 |
Lizenz  |
|
| Titel (primär) | Molecular signatures of angiogenesis inhibitors: a single-embryo untargeted metabolomics approach in zebrafish |
| Autor | Wilhelmi, P.; Haake, V.; Zickgraf, F.M.; Giri, V.; Ternes, P.; Driemert, P.; Nöth, J.; Scholz, S.
; Barenys, M.; Flick, B.; Birk, B.; Kamp, H.; Landsiedel, R.; Funk-Weyer, D. |
| Quelle | Archives of Toxicology |
| Erscheinungsjahr | 2024 |
| Department | ETOX |
| Band/Volume | 98 |
| Heft | 3 |
| Seite von | 943 |
| Seite bis | 956 |
| Sprache | englisch |
| Topic | T9 Healthy Planet |
| Supplements | https://static-content.springer.com/esm/art%3A10.1007%2Fs00204-023-03655-5/MediaObjects/204_2023_3655_MOESM1_ESM.xlsx https://static-content.springer.com/esm/art%3A10.1007%2Fs00204-023-03655-5/MediaObjects/204_2023_3655_MOESM2_ESM.xlsx https://static-content.springer.com/esm/art%3A10.1007%2Fs00204-023-03655-5/MediaObjects/204_2023_3655_MOESM3_ESM.xlsx https://static-content.springer.com/esm/art%3A10.1007%2Fs00204-023-03655-5/MediaObjects/204_2023_3655_MOESM4_ESM.docx |
| Keywords | Untargeted metabolomics; Zebrafish embryo; Developmental toxicity; Angiogenesis |
| Abstract | Angiogenesis is a key process in embryonic development, a disruption of this process can lead to severe developmental defects, such as limb malformations. The identification of molecular perturbations representative of antiangiogenesis in zebrafish embryo (ZFE) may guide the assessment of developmental toxicity from an endpoint- to a mechanism-based approach, thereby improving the extrapolation of findings to humans. Thus, the aim of the study was to discover molecular changes characteristic of antiangiogenesis and developmental toxicity. We exposed ZFEs to two antiangiogenic drugs (SU4312, sorafenib) and two developmental toxicants (methotrexate, rotenone) with putative antiangiogenic action. Molecular changes were measured by performing untargeted metabolomics in single embryos. The metabolome response was accompanied by the occurrence of morphological alterations. Two distinct metabolic effect patterns were observed. The first pattern comprised common effects of two specific angiogenesis inhibitors and the known teratogen methotrexate, strongly suggesting a shared mode of action of antiangiogenesis and developmental toxicity. The second pattern involved joint effects of methotrexate and rotenone, likely related to disturbances in energy metabolism. The metabolites of the first pattern, such as phosphatidylserines, pterines, retinol, or coenzyme Q precursors, represented potential links to antiangiogenesis and related developmental toxicity. The metabolic effect pattern can contribute to biomarker identification for a mechanism-based toxicological testing. |
| dauerhafte UFZ-Verlinkung | https://www.ufz.de/index.php?en=20939&ufzPublicationIdentifier=28775 |
| Wilhelmi, P., Haake, V., Zickgraf, F.M., Giri, V., Ternes, P., Driemert, P., Nöth, J., Scholz, S., Barenys, M., Flick, B., Birk, B., Kamp, H., Landsiedel, R., Funk-Weyer, D. (2024): Molecular signatures of angiogenesis inhibitors: a single-embryo untargeted metabolomics approach in zebrafish Arch. Toxicol. 98 (3), 943 - 956 10.1007/s00204-023-03655-5 |
|